Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Control Of Hypertension Improves The Outcome Of Therapies For Paroxysmal And Persistent Atrial Fibrillation.

Literature DB >> 27957098

Control Of Hypertension Improves The Outcome Of Therapies For Paroxysmal And Persistent Atrial Fibrillation.

Abstract

Hypertension is known to increase the risk of atrial fibrillation. It has a role to play in atrial fibrosis and remodeling which tends to propagate further atrial fibrillation. Current anti arrhythmic therapy is unsatisfactory due to its toxicity. Management of hypertension offers an attractive target for improving therapy of atrial fibrillation. We examine the current evidence for anti hypertensive therapy in atrial fibrillation.

Entities: Chemical

Year: 2014 PMID： 27957098 PMCID： PMC5135255 DOI： 10.4022/jafib.1092

Source DB: PubMed Journal: J Atr Fibrillation ISSN： 1941-6911

Keyword Cloud
References

31 in total

Review 1. Prevention of atrial fibrillation by Renin-Angiotensin system inhibition a meta-analysis.

Authors: Markus P Schneider; Tsushung A Hua; Michael Böhm; Kristian Wachtell; Sverre E Kjeldsen; Roland E Schmieder
Journal: J Am Coll Cardiol Date: 2010-05-25 Impact factor: 24.094

2. Initiation of atrial fibrillation by ectopic beats originating from the pulmonary veins: electrophysiological characteristics, pharmacological responses, and effects of radiofrequency ablation.

Authors: S A Chen; M H Hsieh; C T Tai; C F Tsai; V S Prakash; W C Yu; T L Hsu; Y A Ding; M S Chang
Journal: Circulation Date: 1999-11-02 Impact factor: 29.690

3. Impact of angiotensin-converting enzyme-inhibitors and angiotensin receptor blockers on long-term outcome of catheter ablation for atrial fibrillation.

Authors: Muzahir H Tayebjee; Antonio Creta; Stefan Moder; Ross J Hunter; Mark J Earley; Mehul B Dhinoja; Richard J Schilling
Journal: Europace Date: 2010-08-02 Impact factor: 5.214

4. Maintenance of sinus rhythm after electrical cardioversion of persistent atrial fibrillation; sotalol vs bisoprolol.

Authors: A Plewan; G Lehmann; G Ndrepepa; J Schreieck; E U Alt; A Schömig; C Schmitt
Journal: Eur Heart J Date: 2001-08 Impact factor: 29.983

5. Randomized trial of angiotensin II-receptor blocker vs. dihydropiridine calcium channel blocker in the treatment of paroxysmal atrial fibrillation with hypertension (J-RHYTHM II study).

Authors: Takeshi Yamashita; Hiroshi Inoue; Ken Okumura; Itsuo Kodama; Yoshifusa Aizawa; Hirotsugu Atarashi; Tohru Ohe; Hiroshi Ohtsu; Takao Kato; Shiro Kamakura; Koichiro Kumagai; Yoshihisa Kurachi; Yukihiro Koretsune; Tetsunori Saikawa; Masayuki Sakurai; Toshiaki Sato; Kaoru Sugi; Haruaki Nakaya; Makoto Hirai; Atsushi Hirayama; Masahiko Fukatani; Hideo Mitamura; Tsutomu Yamazaki; Eiichi Watanabe; Satoshi Ogawa
Journal: Europace Date: 2010-12-10 Impact factor: 5.214

10. Effect of single-drug therapy on reduction of left atrial size in mild to moderate hypertension: comparison of six antihypertensive agents.

Authors: J S Gottdiener; D J Reda; D W Williams; B J Materson; W Cushman; R J Anderson
Journal: Circulation Date: 1998-07-14 Impact factor: 29.690

Control Of Hypertension Improves The Outcome Of Therapies For Paroxysmal And Persistent Atrial Fibrillation.

Review 1. Prevention of atrial fibrillation by Renin-Angiotensin system inhibition a meta-analysis.

2. Initiation of atrial fibrillation by ectopic beats originating from the pulmonary veins: electrophysiological characteristics, pharmacological responses, and effects of radiofrequency ablation.

3. Impact of angiotensin-converting enzyme-inhibitors and angiotensin receptor blockers on long-term outcome of catheter ablation for atrial fibrillation.

4. Maintenance of sinus rhythm after electrical cardioversion of persistent atrial fibrillation; sotalol vs bisoprolol.

5. Randomized trial of angiotensin II-receptor blocker vs. dihydropiridine calcium channel blocker in the treatment of paroxysmal atrial fibrillation with hypertension (J-RHYTHM II study).

6. Risk for incident atrial fibrillation in patients who receive antihypertensive drugs: a nested case-control study.

7. Prevention of atrial fibrillation onset by beta-blocker treatment in heart failure: a meta-analysis.

8. Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial.

9. Effect of renal sympathetic denervation on the inducibility of atrial fibrillation during rapid atrial pacing.

10. Effect of single-drug therapy on reduction of left atrial size in mild to moderate hypertension: comparison of six antihypertensive agents.